![Gerrit Hagens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Gerrit Hagens first degree
Entity | Entity type | Industry | |
---|---|---|---|
Natimab Therapeutics Srl
![]() Natimab Therapeutics Srl BiotechnologyHealth Technology Natimab Therapeutics Srl operates as a biotechnology company. It specializes in the identification and early-stage clinical development of monoclonal antibodies (mAbs) for the treatment of infectious diseases. The company was founded by Gianni Garotta, Maurizio Denaro, Marianne Murphy and Gerritt Hagens in 2009 and is headquartered in Colleretto Giacosa, Italy.
3
| Holding Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gerrit Hagens via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
The Wistar Institute
![]() The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Biotechnology | Corporate Officer/Principal | |
University of Milan | College/University | Doctorate Degree | |
Proterris (Portugal) - Investigação e Desenvolvimento
![]() Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Proterris (Portugal) - Investigação e Desenvolvimento de Produtos Farmacêuticos, Sociedade Unipessoal Lda. develops Carbon Monoxide-Releasing Molecules (CORMs) for therepy. The company was founded by Carlos José Rodrigues Crispim Romão, Werner Ernest Hass, Nuno Manuel de Castro Santos Arante e Oliveira and Stan Kugell on January 4, 2002 and is headquartered in Oeiras, Portugal. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
Bracco Imaging SpA
![]() Bracco Imaging SpA Medical SpecialtiesHealth Technology Bracco Imaging SpA manufactures and develops diagnostic imaging solutions for public and private hospitals, imaging centers and private practices. The firm's services include radiology, X-ray imaging, magnetic resonance imaging and ultrasound applications. The company was founded in 1985 and is headquartered in Milan, Italy. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Roche Corp. | Corporate Officer/Principal | ||
Fondazione Irccs Istituto Nazionale Dei Tumori | College/University | Corporate Officer/Principal | |
OncoNOx ApS
![]() OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder |
Statistics
International
Italy | 6 |
United States | 5 |
Switzerland | 3 |
Portugal | 2 |
Denmark | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 4 |
Finance | 2 |
Operational
Corporate Officer/Principal | 10 |
Founder | 4 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Doctorate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Gianni Garotta | 12 |
Maurizio Denaro | 3 |
Marianne Murphy | 1 |
- Stock Market
- Insiders
- Gerrit Hagens
- Company connections